—

BB Biotech AG (BION.SW) — the peer cohort

As of 2026-10-27 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

BB Biotech AG ranks 1 of 7 in its cohort on the Closelooknet composite (74/100) — the highest reading in the cohort.

NameCompositeMomentumQualityValuationSignalOff 52w high
BION.SW BB Biotech AG 74 65 96 81 info 11.8%
ARGX.BR Argen-X 64 72 76 30 info 15.4%
ONC BeiGene, Ltd. 64 82 65 31 ok 5.8%
UCB.BR UCB SA 64 63 71 54 info 6.8%
ARGX argenx NV ADR 63 67 75 29 info 17.7%
RIGL Rigel Pharmaceuticals Inc 62 94 90 73 ok 3.2%
CAI Caris Life Sciences, Inc. Common Stock 61 98 62 25 ok 1.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-27

Quick answers

Who are BB Biotech AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Argen-X (ARGX.BR), BeiGene, Ltd. (ONC), UCB SA (UCB.BR), argenx NV ADR (ARGX), Rigel Pharmaceuticals Inc (RIGL), Caris Life Sciences, Inc. Common Stock (CAI).

How does BION.SW score against its peers?

BB Biotech AG's composite reads 74/100, ranking 1 of 7 in its cohort as of 2026-10-27 — the highest in the cohort. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.